SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study
항체 결핍증이 있는 개인의 SARS-CoV-2 백신 반응: COV-AD 연구 결과
Article
[키워드] Antibiotic prophylaxis
antibody
Antibody Response
assays
AstraZeneca
Breakthrough infection
cellular response
clearance
Cohort
controls
COVID-19
CVID
deficiency
determine
dose
Efficacy
ELISA
Evidence
finding
General population
healthy control
IgG
immune response
immunoglobulin replacement therapy
Inborn error
inborn errors of immunity
individual
Infection
interferon gamma
less
magnitude
morbidity and mortality
nasopharyngeal swabs
neutralisation
neutralising
no difference
occurred
participant
Patient
PCR
PCR positive
Pfizer/BioNTech
post vaccination
Prevent
Primary Immunodeficiency
receiving
recipient
recruited
recurrent infection
reduced
remained
reported
respond
response
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
secondary
secondary antibody
secondary immunodeficiency
seropositive
Seropositivity
significantly
T cell response
the antibody response
vaccination
Vaccine
Vaccines
[DOI] 10.1007/s10875-022-01231-7 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s10875-022-01231-7 PMC 바로가기 [Article Type] Article